We have previously shown that the administration of a PSA-based vaccine resulted in the generation of PSA-reactive T cells in this cohort of patients with surgically incurable prostate cancer (Meidenbauer et al, 2000). This evidence concerns the gene KLK3 and Familial prostate cancer.